Literature DB >> 7426334

Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours.

S A Eccles, S E Heckford, P Alexander.   

Abstract

Cyclosporin A (Cy A), a novel immunosuppressive agent with apparently selective inhibitory effects on T lymphocytes and little myelotoxicity, was tested for its effects on a variety of syngeneic animal tumours including sarcomas, carcinomas and a T-cell lymphoma. Cy A, given orally or parenterally in repeated doses, had no effect on the growth rates of any of the tumours tested, but a highly significant effect on metastasis was seen in many cases. All the sarcomas examined in both rats and mice, and also the lymphoma, showed a marked increase in their metastases, in some cases even when administration of Cy A was delayed until after excision of the "primary" tumour implants. In contrast no effect of Cy A on metastasis was observed in animals bearing poorly immunogenic mammary or squamous-cell carcinomas. The metastases developing in Cy A-treated animals, when transplanted into normal syngeneic animals, showed no evidence of enhanced metastatic potential compared with their "parent tumours.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7426334      PMCID: PMC2010386          DOI: 10.1038/bjc.1980.224

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  Immunologically-mediated restraint of latent tumour metastases.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1975-09-04       Impact factor: 49.962

2.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

3.  Mode of action of cyclosporin A: a new immunosuppressive agent.

Authors:  D J White; R Y Calne; A Plumb
Journal:  Transplant Proc       Date:  1979-03       Impact factor: 1.066

4.  Clinical and pharmacological implications of cancer cell differentiation and heterogeneity.

Authors:  P Calabresi; D L Dexter; G H Heppner
Journal:  Biochem Pharmacol       Date:  1979-06-15       Impact factor: 5.858

5.  Macrophage content of tumours in relation to metastatic spread and host immune reaction.

Authors:  S A Eccles; P Alexander
Journal:  Nature       Date:  1974-08-23       Impact factor: 49.962

Review 6.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

7.  Immunogenicity of chemically induced murine colon cancers.

Authors:  L P Belnap; P H Cleveland; M E Colmerauer; R M Barone; Y H Pilch
Journal:  Cancer Res       Date:  1979-04       Impact factor: 12.701

8.  Metastasis in the nude rat associated with lack of immune response.

Authors:  S A Eccles; J M Styles; S M Hobbs; C J Dean
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

9.  Immunity as the predominant factor determining metastasis by murine lymphomas.

Authors:  G C Davey; G A Currie; P Alexander
Journal:  Br J Cancer       Date:  1979-10       Impact factor: 7.640

10.  Metastatic colonization potential of primary tumour cells in mice.

Authors:  D Tarin; J E Price
Journal:  Br J Cancer       Date:  1979-06       Impact factor: 7.640

View more
  20 in total

1.  Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines.

Authors:  S J Hall; T C Thompson
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

2.  Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma.

Authors:  R J Lawrance
Journal:  Ann R Coll Surg Engl       Date:  1990-09       Impact factor: 1.891

3.  The use of quantitative genetics for estimating the non-inherited and inherited contributions to metastasis formation.

Authors:  J P Volpe
Journal:  Clin Exp Metastasis       Date:  1992-05       Impact factor: 5.150

4.  Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.

Authors:  J P Volpe; L Milas
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

5.  Gene expression profiles of primary breast tumors maintained in distant metastases.

Authors:  Britta Weigelt; Annuska M Glas; Lodewyk F A Wessels; Anke T Witteveen; Johannes L Peterse; Laura J van't Veer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-09       Impact factor: 11.205

6.  Monoclonal antibodies to rat sarcomata. II. A syngeneic IgG2b antibody with anti-tumour activity.

Authors:  S M North; C J Dean
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

7.  Cyclosporine and partial liver allotransplants in a simplified rat model.

Authors:  S Inoue; N Kawano; Y Morioka
Journal:  Jpn J Surg       Date:  1985-07

8.  Spontaneous metastasis: random or selective?

Authors:  L Milas; L J Peters; H Ito
Journal:  Clin Exp Metastasis       Date:  1983 Oct-Dec       Impact factor: 5.150

9.  The production of hybridomas from the gut associated lymphoid tissue of tumour bearing rats. I. Mesenteric nodes as a source of IgG producing cells.

Authors:  C J Dean; J M Styles; L A Gyure; J Peppard; S M Hobbs; E Jackson; J G Hall
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

10.  Transplantation of human or rodent tumors into cyclosporine-treated mice: a feasible model for studies of tumor biology and chemotherapy.

Authors:  H J Fingert; A Treiman; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.